ST-Segment Elevation Myocardial Infarction: Door to Balloon Time Improvement Project
Saad Al Bugami1, Jamilah Alrahimi2, Abdullah Almalki2
1King Saud bin Abdulaziz University for Health Sciences; King Faisal Cardiac Center, King Saud bin Abdulaziz Medical City, Jeddah, Saudi Arabia.
Cardiology Research
|February 16, 2017
Summary
This study improved door-to-balloon times for ST-segment elevation myocardial infarction (STEMI) patients, with 54% achieving the benchmark. Delays were linked to patient identification, ECGs, and transport to the cardiac catheterization lab.
Area of Science:
- Cardiology
- Emergency Medicine
- Quality Improvement
Background:
- Primary percutaneous coronary intervention (PCI) is crucial for ST-segment elevation myocardial infarction (STEMI) treatment.
- Door-to-balloon (D2B) time is a critical metric for STEMI patient outcomes, with a benchmark of ≤90 minutes.
- In 2014, only 25% of STEMI patients at King Faisal Cardiac Center (KFCC) met the D2B goal.
Purpose of the Study:
- To identify causes of delay in STEMI patients requiring primary PCI.
- To implement strategies to reduce D2B time.
- To evaluate the impact of interventions on D2B times at KFCC.
Main Methods:
- Prospective data collection of STEMI patients within 24 hours of chest pain onset (January-December 2015).
- Defined process boundaries from emergency department arrival to balloon inflation during PCI.
- Utilized specific metrics to identify process defects and drive change.
Main Results:
- 54% of 37 STEMI patients achieved the target D2B time of ≤90 minutes, a significant improvement.
- Delays were attributed to late patient identification, ECG acquisition, catheterization lab activation, and transport.
- 24.4% had D2B times between 91-120 minutes, and 21.6% exceeded 120 minutes.
Conclusions:
- A 54% achievement rate for D2B time indicates a measurable improvement in STEMI care.
- Addressing delays in patient identification, ECG, lab activation, and transport is key to meeting the D2B benchmark.
- Continuous quality improvement efforts are essential for optimizing STEMI treatment pathways.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
1.3K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome IV: Interprofessional Care
360
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
360
Acute Coronary Syndrome III: Diagnostic Studies
355
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
355


